Production (Stage)
Burcon Nutrascience Corporation
BU.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.44% | 14.64% | -61.55% | 4.02% | -13.39% |
| Total Depreciation and Amortization | 62.22% | 37.97% | 27.65% | 18.94% | 52.89% |
| Total Amortization of Deferred Charges | -6.14% | -2.84% | -1.65% | -1.79% | 0.39% |
| Total Other Non-Cash Items | 116.07% | 27.04% | 340.00% | -11.35% | 29.94% |
| Change in Net Operating Assets | 303.10% | -3,580.82% | 452.93% | -324.45% | -125.69% |
| Cash from Operations | 43.88% | 4.25% | 14.19% | -47.67% | -88.26% |
| Capital Expenditure | -224.47% | 76.20% | -20.61% | -643.02% | 35.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7,629.23% | -63.46% | -50.70% | 5.91% | 64.56% |
| Cash from Investing | -17,829.31% | 80.77% | -286.00% | -3,643.33% | 72.77% |
| Total Debt Issued | -78.50% | -- | -- | -- | 0.00% |
| Total Debt Repaid | -160.12% | 39.13% | -18.89% | -1,113.89% | -1,580.00% |
| Issuance of Common Stock | 115.64% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -246.04% | -- | -- | 51.22% | 70.86% |
| Cash from Financing | 65.50% | 10,633.82% | 1,140.30% | -101.91% | 568.94% |
| Foreign Exchange rate Adjustments | -86.09% | 168.67% | -153.30% | 176.96% | 618.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.31% | 72.08% | 17.64% | -194.43% | 2,421.96% |